The fat wrapped around your heart sits on the muscle with no fascia in between
In short
Epicardial adipose tissue (EAT) is a metabolically and endocrinologically active visceral fat depot that contacts the myocardium and the coronary arteries with no intervening fascial barrier. Because of that position, what the tissue secretes acts on cardiac structures through paracrine and vasocrine signaling. In obesity and metabolic syndrome the depot undergoes adipocyte hypertrophy, immune cell infiltration and dysregulated adipokine secretion, shifting from a beige-like thermogenic tissue to a white, pro-inflammatory one — a change linked to myocardial fibrosis (TGF-β/SMAD), arrhythmogenesis (disrupted connexin-mediated conduction and the adipose-neural axis) and coronary atherosclerosis.
Visceral fat usually means fat inside the abdomen, but the heart carries its own. Epicardial adipose tissue (EAT) lies directly on the surface of the heart muscle and over the coronary arteries, and there is no fascia separating them. That is the decisive difference from fat elsewhere: signalling molecules released by the tissue act on the structure immediately next to it rather than travelling through the circulation first.
What it does when things are normal
The depot has a job. The physiological roles the review lists are maintaining lipid homeostasis, providing mechanical protection for a constantly moving organ, and thermogenesis. That last one matters: healthy epicardial fat behaves closer to beige, heat-producing tissue. It is not a harmful tissue by default — it becomes a problem when its character changes.
What changes when it turns pathological
- Structure — adipocytes enlarge, immune cells infiltrate, and adipokine secretion becomes dysregulated.
- Phenotype — a beige-like thermogenic depot shifts toward white, pro-inflammatory fat.
- Fibrosis — fibroblast-to-myofibroblast differentiation via TGF-β/SMAD and biomechanical pathways drives myocardial fibrosis.
- Arrhythmia — connexin-mediated conduction is disrupted and the adipose-neural axis is activated.
- Coronaries — local inflammatory signalling facilitates atherosclerosis.
The renin-angiotensin-aldosterone system is named as a key mediator: AT1 receptor-driven inflammatory cascades push fibrosis forward, while the ACE2/Ang 1-7/MasR axis works in the counter-regulatory direction.
What a lifter takes from it
In a sport with phases where body weight has to go up, the use of this review is the reminder that where the fat goes is part of the question. A single body fat percentage says nothing about the tissue sitting on the heart. And the change that starts the process — adipocyte hypertrophy — is the same phenomenon seen elsewhere: what happens metabolically when existing cells stretch to their limit is covered in fat cells and the cytoskeleton, and how much fat accompanies muscle during a bulk is in the fat-to-muscle ratio of a bulk. It also lines up with the finding that aerobic work lowered inflammatory markers most consistently.
This is a narrative review of literature from 2000 to 2025. Echocardiographic thickness and CT/MRI volume have shown prognostic associations, but standardized cutoffs across imaging modalities are still missing, and strategies such as GLP-1 receptor agonists or induced re-browning remain preliminary. This is not a number you can measure at the gym.
Frequently asked questions
What is epicardial adipose tissue?
It is a visceral fat depot lying directly on the surface of the heart muscle and over the coronary arteries. It is metabolically and endocrinologically active, and unlike fat elsewhere there is no fascial layer separating it from the myocardium.
Why does its position matter?
With no fascial barrier in between, molecules secreted by the tissue act on the adjacent myocardium and coronary arteries through paracrine and vasocrine signaling, reaching neighbouring structures without circulating first.
Is epicardial fat harmful by nature?
No. Physiologically it supports lipid homeostasis, provides mechanical protection for the beating heart, and contributes to thermogenesis, behaving like beige tissue when healthy. The problem arises when obesity and metabolic syndrome shift it toward a white, pro-inflammatory phenotype.
What does that shift do to the heart?
It promotes myocardial fibrosis through TGF-β/SMAD signalling, contributes to arrhythmogenesis by disrupting connexin-mediated conduction and activating the adipose-neural axis, and facilitates coronary atherosclerosis through local inflammatory signalling.
Can epicardial fat be measured and managed?
Echocardiographic thickness and CT or MRI volume have shown prognostic associations, but standardized cutoff values across imaging modalities have not been established and large prospective trials validating risk stratification based on it are still lacking.
Source: PubMed